Compounds > pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid
Page last updated: 2024-11-03

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Anterior Ischemic Optic Neuropathy

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Anterior Ischemic Optic Neuropathy in 1 studies

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Domercq, M1
Perez-Samartin, A1
Aparicio, D1
Alberdi, E1
Pampliega, O1
Matute, C1

Other Studies

1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Anterior Ischemic Optic Neuropathy

ArticleYear
P2X7 receptors mediate ischemic damage to oligodendrocytes.
    Glia, 2010, Apr-15, Volume: 58, Issue:6

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Animals, Newborn; Axons; Calcium; Cell Death; Co

2010